Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
18.76
+0.66 (3.65%)
At close: Jun 26, 2026, 4:00 PM EDT
18.78
+0.02 (0.11%)
After-hours: Jun 26, 2026, 7:23 PM EDT

Company Description

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment.

It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.

In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair.

Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products.

Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems.

It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally.

Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995.

Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings logo
Country United States
Founded 1989
IPO Date Aug 16, 1995
Industry Medical Devices
Sector Healthcare
Employees 4,427
CEO Stuart Essig

Contact Details

Address:
1100 Campus Road
Princeton, New Jersey 08540
United States
Phone 609 275 0500
Website integralife.com

Stock Details

Ticker Symbol IART
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000917520
CUSIP Number 457985208
ISIN Number US4579852082
Employer ID 51-0317849
SIC Code 3841

Key Executives

Name Position
Dr. Stuart M. Essig Ph.D. Chief Executive Officer, President and Chairman
Lea Daniels Knight Executive Vice President and Chief Financial Officer
Robert T. Davis Jr. Executive Vice President and President of Tissue Technologies
Michael J. McBreen Chief Commercial Officer
Harvinder Pal Singh Executive Vice President and President of International Business
Jeffrey A. Mosebrook Senior Vice President of Finance and Principal Accounting Officer
Teshtar Elavia Corporate Vice President and Chief Technology Officer
Christopher Ward Senior Director of Investor Relations
Michael D. Hutchinson Executive Vice President, Chief Legal Officer and Secretary
Laurene Isip Vice President of Global Corporate Communications and Public Relations

Latest SEC Filings

Date Type Title
May 29, 2026 SD Form - SD
May 15, 2026 SCHEDULE 13G Filing
May 8, 2026 S-8 Securities to be offered to employees in employee benefit plans
May 8, 2026 8-K Current Report
May 5, 2026 10-Q Quarterly Report
May 5, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
May 5, 2026 8-K Current Report
May 5, 2026 8-K Current Report
Apr 15, 2026 8-K Current Report
Apr 6, 2026 DEF 14A Other definitive proxy statements